Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Ovarian Cancer and Immune Response to Flu Vaccine
- Status
- COMPLETED
- Phase
- N/A
Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172
- Status
- WITHDRAWN
- Phase
- NA
Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
MRI in Staging Ovarian Cancer Using MRI Contrast Agent
- Status
- UNKNOWN
- Phase
- N/A
A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer
- Status
- COMPLETED
- Phase
- NA